https://de.marketscreener.com/kurs/aktie/PAION-AG-462044/news/PAION-GIBT-POSITIVE-REMIMAZOLAM-TOPLINE-DATEN-IN-EU-PHASE-III-STUDIE-IN-ALLGEMEINANASTHESIE-BEKAN-31824631/?utm_source=telegram&utm_medium=social&utm_campaign=share